Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CASR | P41180 | 2/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16952633 | 0.83 | AOC3 (0.53) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL16952787 | 0.83 | CASR (0.50) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL13814395 | 0.82 | AOC3 (0.51) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL11618270 | 0.82 | AOC3 (0.51) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL2322739 | 0.82 | CASR (0.47) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL6702192 | 0.82 | MTNR1A (0.46) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL8317373 | 0.82 | CASR (0.51) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL14162717 | 0.81 | CASR (0.51) | AOC3L3MBTL1CASRTAAR1 | |
| Ammonia Solution, Strong SCHEMBL6001103 | 0.81 | CASR (0.51) | AOC3L3MBTL1CASRMTNR1AMTNR1B | |
| SCHEMBL10192231 | 0.81 | CASR (0.51) | AOC3L3MBTL1CASRTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234220-A1 | Oxooxetanes as Fungicidal Agents | BAYER CROPSCIENCE AG (DE) | 2010-09-16 | — | — | US | disclosed |
| EP-0702686-B1 | ANTIMICROBIAL SILOXANE QUATERNARY AMMONIUM SALTS | KIMBERLY CLARK CO (US) | 2001-09-05 | — | — | EP | disclosed |
| US-5853641-A | Method for preparing polyolefin fibers containing antimicrobial siloxane quarternary ammonium salts | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1998-12-29 | — | — | US | disclosed |
| US-5854147-A | Non-woven web containing antimicrobial siloxane quaternary ammonium salts | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1998-12-29 | — | — | US | disclosed |
| US-5853883-A | Polyolefin fibers containing antimicrobial siloxane quaternary ammonium salts | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1998-12-29 | — | — | US | disclosed |
| US-5777010-A | BLEND WITH THERMOPLASTIC POLYOLEFIN | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5569732-A | TRISILOXANE | KIMBERLY-CLARK CORPORATION (US) | 1996-10-29 | — | — | US | disclosed |
| US-5567372-A | Method for preparing a nonwoven web containing antimicrobial siloxane quaternary ammonium salts | KIMBERLY-CLARK CORPORATION (US) | 1996-10-22 | — | — | US | disclosed |
| EP-0702686-A1 | ANTIMICROBIAL SILOXANE QUATERNARY AMMONIUM SALTS | KIMBERLY-CLARK CORPORATION (US) | 1996-03-27 | — | — | EP | disclosed |
| WO-1994029325-A1 | ANTIMICROBIAL SILOXANE QUATERNARY AMMONIUM SALTS | KIMBERLY-CLARK CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234220-A1 | Oxooxetanes as Fungicidal Agents | CYP51A1, PNPO, AOX1 | AOC3 9/4885L3MBTL1 3994/4885CASR 4522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.